External composition for skin containing an enzyme-treated saponin fraction derived from the root of Camellia sinensis
US10022415B2 · kind B2 · utility
0Cited by
1References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 3, 2015 |
| Grant date | Jul 17, 2018 |
| Priority date | — |
| Expiry date | Jan 23, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61Q19/008
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a composition comprising the saponin fraction derived from the root of camellia sinensis, and more specifically, a composition which, by using the saponin fraction isolated after treating the extract of the root of camellia sinensis with an enzyme, can reduce the cellular toxicity over the conventional saponin fraction derived from the root of camellia sinensis to enhance stability to the skin, and can comprise the saponin fraction obtained by such method in much higher amounts to provide the more superior skin condition improvement effect.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.